cardiology
Medicines

Don’t panic over valsartan recall, patients told


Patients are being warned not to stop taking the valsartan-containing products Dilart and Dilart HCT despite the tablets being subject to a recall because of contamination. The TGA says the angiotensin II antagonist products have been found to contain trace impurities of a possible carcinogen, N-nitrosodiethylamine (NDEA), but the risk is not great enough to ...

Already a member?

Enter your email to keep reading.


OR